S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:PIII

P3 Health Partners (PIII) Stock Price, News & Analysis

$1.03
+0.01 (+0.98%)
(As of 03/28/2024 ET)
Today's Range
$1.00
$1.12
50-Day Range
$0.71
$1.21
52-Week Range
$0.66
$5.56
Volume
397,444 shs
Average Volume
437,683 shs
Market Capitalization
$322.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75

P3 Health Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
361.2% Upside
$4.75 Price Target
Short Interest
Healthy
4.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.24mentions of P3 Health Partners in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.98) to ($0.54) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.00 out of 5 stars

Medical Sector

623rd out of 939 stocks

Health Services Industry

6th out of 10 stocks

PIII stock logo

About P3 Health Partners Stock (NASDAQ:PIII)

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

PIII Stock Price History

PIII Stock News Headlines

P3 Health Partners: Q4 Earnings Insights
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
P3 Health Partners (PIII) to Release Earnings on Thursday
P3 Health Partners (PIII) Set to Announce Earnings on Thursday
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
Why Health Management Company P3 Health Partners Shares Are Up Today
P3 Health Partners Inc Class A PIII
55,508
P3 Health Partners Inc - Ordinary Shares - Class A
P3 Health Partners Recent Insider Activity
See More Headlines
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PIII
Fax
N/A
Employees
600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.75
High Stock Price Target
$5.00
Low Stock Price Target
$4.50
Potential Upside/Downside
+361.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-270,130,000.00
Pretax Margin
-54.92%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$51.50 per share
Book Value
$0.15 per share

Miscellaneous

Free Float
259,676,000
Market Cap
$322.48 million
Optionable
Not Optionable
Beta
1.05
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Sherif Abdou F.A.C.E.P. (Age 63)
    FACP, M.D., Co-Founder, CEO & Director
    Comp: $7.1M
  • Dr. Amir Bacchus M.B.A. (Age 59)
    M.D., Co-Founder, Chief Medical Officer & Director
    Comp: $4.3M
  • Mr. Atul Kavthekar
    CFO & Chief Accounting Officer
  • Mr. William Bettermann
    Executive VP & COO
  • Mr. Devery Goodey
    Senior Vice President of Technology
  • Roy Youngblood
    Director of Compliance
  • Ms. Kassi Belz APR
    Executive Vice President of Communications, Culture & Engagement
  • Mr. Todd Lefkowitz MHA
    Chief Managed Care Officer
  • Ms. Sarah Bussmann B.S.N.
    CRNI, M.H.A., R.N., Chief of Staff
  • Mr. David Yarger
    Market President of Arizona Market

PIII Stock Analysis - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings
or view top-rated stocks.

What is P3 Health Partners' stock price target for 2024?

3 brokers have issued 12-month price targets for P3 Health Partners' stock. Their PIII share price targets range from $4.50 to $5.00. On average, they expect the company's share price to reach $4.75 in the next year. This suggests a possible upside of 361.2% from the stock's current price.
View analysts price targets for PIII
or view top-rated stocks among Wall Street analysts.

How have PIII shares performed in 2024?

P3 Health Partners' stock was trading at $1.41 on January 1st, 2024. Since then, PIII stock has decreased by 27.0% and is now trading at $1.03.
View the best growth stocks for 2024 here
.

When is P3 Health Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our PIII earnings forecast
.

What guidance has P3 Health Partners issued on next quarter's earnings?

P3 Health Partners updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are P3 Health Partners' major shareholders?

P3 Health Partners' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.50%), Vanguard Group Inc. (0.50%), Northern Trust Corp (0.10%), GSA Capital Partners LLP (0.09%), Nuveen Asset Management LLC (0.05%) and Barclays PLC (0.02%). Insiders that own company stock include Atul Kavthekar, Michael Balkin, Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago and Sherif Abdou.
View institutional ownership trends
.

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PIII) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners